Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heena Santry

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 14, 2008
Bariatric surgery: a history of empiricism, a future in scienceJohn C Alverdy, Vivek Prachand, Brody Flanagan, et al.
Pancreas|September 13, 2022
Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal AdenocarcinomaAhmad Hamad, Norah Crossnohere, Aslam Ejaz, et al.
The Journal of Surgical Research|September 12, 2020
The Need for Accurate Risk Assessment in a High-Risk Patient Population: A NSQIP Study Evaluating Outcomes of Cholecystectomy in the Patient With CancerGregory Metzger, Chelsea Horwood, J C Chen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 6, 2012
Centre volume and resource consumption in liver transplantationChristopher W Macomber, Joshua J Shaw, Heena Santry, et al.
Journal of Surgical Oncology|April 20, 2023
Characterizing treatment burden during neoadjuvant therapy for patients with gastrointestinal cancer: A mixed methods analysisNatalie M Bath, Angela Sarna, Marilly Palettas, et al.
The Journal of Surgical Research|August 21, 2020
Analyzing Outcomes Among Older Adults With Necrotizing Soft-Tissue Infections in the United StatesAdara R McCarty, Michael E Villarreal, Robert Tamer, et al.
World Journal of Gastrointestinal Oncology|August 11, 2022
Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative studyLena Stevens, Zachary J Brown, Ryan Zeh, et al.
Journal of Clinical Medicine|April 25, 2020
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled TrialsJordan M Cloyd, Victor Heh, Timothy M Pawlik, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 12, 2021
Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic ductal adenocarcinomaLena Schreiber, Ryan Zeh, Christina Monsour, et al.
Annals of Surgery|August 29, 2023
Quality of Life and Real-time Patient Experience During Neoadjuvant Therapy: A Prospective Cohort StudyAlexander H Shannon, Angela Sarna, Luke Bressler, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 14, 2008
Bariatric surgery: a history of empiricism, a future in scienceJohn C Alverdy, Vivek Prachand, Brody Flanagan, et al.
Pancreas|September 13, 2022
Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal AdenocarcinomaAhmad Hamad, Norah Crossnohere, Aslam Ejaz, et al.
The Journal of Surgical Research|September 12, 2020
The Need for Accurate Risk Assessment in a High-Risk Patient Population: A NSQIP Study Evaluating Outcomes of Cholecystectomy in the Patient With CancerGregory Metzger, Chelsea Horwood, J C Chen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 6, 2012
Centre volume and resource consumption in liver transplantationChristopher W Macomber, Joshua J Shaw, Heena Santry, et al.
Journal of Surgical Oncology|April 20, 2023
Characterizing treatment burden during neoadjuvant therapy for patients with gastrointestinal cancer: A mixed methods analysisNatalie M Bath, Angela Sarna, Marilly Palettas, et al.
The Journal of Surgical Research|August 21, 2020
Analyzing Outcomes Among Older Adults With Necrotizing Soft-Tissue Infections in the United StatesAdara R McCarty, Michael E Villarreal, Robert Tamer, et al.
World Journal of Gastrointestinal Oncology|August 11, 2022
Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative studyLena Stevens, Zachary J Brown, Ryan Zeh, et al.
Journal of Clinical Medicine|April 25, 2020
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled TrialsJordan M Cloyd, Victor Heh, Timothy M Pawlik, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 12, 2021
Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic ductal adenocarcinomaLena Schreiber, Ryan Zeh, Christina Monsour, et al.
Annals of Surgery|August 29, 2023
Quality of Life and Real-time Patient Experience During Neoadjuvant Therapy: A Prospective Cohort StudyAlexander H Shannon, Angela Sarna, Luke Bressler, et al.
Pageof 3